Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
UBS
Healthtrust
Harvard Business School
Farmers Insurance

Generated: August 23, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca AB v. Dexcel Ltd. (D. Del. 2006)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

AstraZeneca AB v. Dexcel Ltd. (D. Del. 2006)

Docket   Try a Free Trial Date Filed 2006-05-30
Court District Court, D. Delaware Date Terminated 2007-10-02
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand None Referred To
Parties AKTIEBOLAGET HASSLE; ASTRAZENECA AB; ASTRAZENECA LP; CIPLA, LTD.; DEXCEL LTD.; DEXCEL PHARMA TECHNOLOGIES; DEXCEL PHARMA TECHNOLOGIES LTD.; DEXXON LTD.; KBI INC.; KBI-E INC.
Patents 4,128,658; 4,853,230; 5,690,960; 5,753,265; 5,817,338; 6,150,380; 6,403,616; 6,428,810; 6,632,842
Attorneys Ashley Blake Stitzer; Jack B. Blumenfeld; Karen Jacobs; Leslie A. Polizoti; Richard D. Kirk
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca AB v. Dexcel Ltd.

Details for AstraZeneca AB v. Dexcel Ltd. (D. Del. 2006)

Date Filed Document No. Description Snippet Link To Document
2006-05-30 1 Complaint Filed 05/30/2006 Page 13 of 42 U.S. Patent Nov. 21, 2000 6,150,380 l ; ":7§ ?_ j AnX-mypowd@r diffracrogram…06-cv-00358-JJF Document 1 Filed 05/30/2006 6,150,380 1 CRYSTALLINE rossi or carspnazor,iz FIELD OF…CERTIFICATE ()F CORRECTION PATEN'I’ NG. : 6,150,380 Page 1 of § DATED : Noveiiiber 21, 2000 INVENT…of United States Patent Nos. 6,}50,380 (the “’380 patent”); 4,786,505 (the “’505 patent”); and 4,853,2304,853,230 * Aug. 1, 1989 {11} Patent Number: {45} Date of Patent: FOREIGN PATENT DOCUMENTS 0005129 6/1981 External link to document
2007-03-16 100 Notice (Other) means U.S. Patent Application 09/202,251. D. “the ‘380 patcnt” means U.S. Patent No. 6,150,380, which issued…means U.S. Patent Application 09/202,251. D. “the ‘380 paten ” means U.S. Patent No. 6,150,380, which issued… of any other U.S. Patent and Patent Applications relating to the '380 patent by claim of domestic…prosecution of each and every U.S. and foreign patent and patent application related to the ‘3 80 by claim …PCT/SE98/02028, as well as any other U.S. Patent and Patent A.pplications relating to the foregoing by External link to document
2007-03-20 103 Notice to Take Deposition means U.S. Patent Application 09/202,251. G. “the ‘380 patent” means U.S. Patent No. 6,150,380. H. “omeprazole… the ‘380 patent J. “the ‘505 patent” means U.S. Patent No. 4,786,505. K. “the ‘230 patent” means U.…U.S. Patent No. 4,853,230. DEPOSITION TOPICS 1. The ‘380 patent, including without limitation the conception…of omeprazole as defined by claim l of the ‘3 80 patent. l. “omeprazole Forin B” means a form of omeprazole…prosecution thereof as well as each and every U.S. patent application claiming priority, directly or indirectly External link to document
2007-03-20 104 Notice to Take Deposition means U.S. Patent Application 09/202,251. G. “the ‘380 patent” means U.S, Patent No. 6,150,380. H. “omeprazole…ofthe ‘380 patent. J. “the ‘505 patent” means U.S. Patent No. 4,786,505. K. “the ‘230 patent” means U.…U.S. Patent No. 4,853,230. DEPOSITION TOPICS 1. The ‘380 patent, including without limitation the conception…of omeprazole as defined by claim l of the ‘380 patent. I. “omeprazole Form B” means a form of omeprazole…prosecution thereof as well as each and every U.S. patent application claiming priority, directly or indirectly External link to document
2007-03-30 119 Declaration #39;s United States Letter Patent No. 4,128,658 (the " '658 patent") in July 1997. Pur- …specifically to U.S. Patent Nos. 6,150,3 80 (“the ’380 patent”), 6,428,810 (“the ’810 patent”), 5,690,960 (“…(“the ’960 patent”), 5,900,424 (“the ’424 patent”), 6,403,616 (“the ’616 patent”), 5,753,265 (“the ’265…includes U.S. Patent Nos. 4,786,505 (“the ’505 patent”) and 4,853,230 (“the ’230 patent”), samples of …yesterday and we've 7 patent, as does the single patent in suit. the '380 patent, 7 responded with production External link to document
2007-04-02 123 Notice to Take Deposition 380 patent” means U. S. Patent No. 6,150,380, all applications to which U. S. Patent No. 6,150,380 claims…/2007 Page 4 of 18 G. “Patents-in-suit” refers to U. S. Patent Nos. 6,150,380, 4,786,505, and 4,853,230…to any Patent-in-Suit. 54. Any patentability study or any Prior Art search concerning any Patent-in-Suit…Relating to any patent, patent application, supplemental protection certificate, and patent term extension…estoppel of any claim of any Patents-in-Suit or any foreign counterparts to any Patent-in-Suit. 56. Documents External link to document
2007-04-02 124 Notice to Take Deposition /2007 Page 4 of 16 G. “Patents-in-suit” refers to U. S. Patent Nos. 6,150,380, 4,786,505, and 4,853,230…The “‘380 patent” means U. S. Patent No. 6,150,3 80, all applications to which U. S. Patent No. 6,150,…infringement of any Patent-in-Suit. 31. Documents Relating to the validity of any of the Patents-in-Suit. 32… to any Patent-in-Suit. 33. Documents Relating to the ownership, inventorship, patentability, enforceability…,230 and all applications to which these patents claim or are entitled to the benefit of a filing date External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
US Army
Covington
Medtronic
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.